- Home
- ASRV vs ANVS Comparison
ASRV vs ANVS Comparison
Compare ASRV & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASRV | ANVS |
|---|---|---|
| Founded | 1983 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.9M | 69.1M |
| IPO Year | 1994 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ASRV | ANVS |
|---|---|---|
| Price | $3.81 | $1.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 10.6K | ★ 1.2M |
| Earning Date | 04-21-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.16% | N/A |
| EPS Growth | ★ 61.90 | 39.39 |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $14,634,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $34.54 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.64 | $1.54 |
| 52 Week High | $4.04 | $5.50 |
Technical Indicators
Market Signals| Indicator | ASRV | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 42.32 | 43.64 |
| Support Level | $3.62 | $1.79 |
| Resistance Level | $3.96 | $2.57 |
| Average True Range (ATR) | 0.13 | 0.17 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 28.95 | 24.29 |
Price Performance
Historical ComparisonAbout ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.
About ANVS Annovis Bio Inc.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.